Zhejiang Jingxin Pharmaceutical Co Ltd Net Asset Quality Index
Zhejiang Jingxin Pharmaceutical Co Ltd net asset quality index. Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Net Asset Quality Index of 75.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥7.95 Billion minus total liabilities of CN¥1.91 Billion yields net assets of CN¥6.04 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 002020 book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Zhejiang Jingxin Pharmaceutical Co Ltd (2001–2025)
Net asset quality index of Zhejiang Jingxin Pharmaceutical Co Ltd from 2001 to 2025. This chart shows how Zhejiang Jingxin Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 25 annual periods from 2001 to 2025. As of June 2026, the index stands at 75.9%, representing net assets of CN¥6.04 Billion against total assets of CN¥7.95 Billion CNY. Check 002020 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Zhejiang Jingxin Pharmaceutical Co Ltd Net Asset Quality Index by Year (2001–2025)
Zhejiang Jingxin Pharmaceutical Co Ltd net asset quality index by year from 2001 to 2025. The table below presents the year-by-year Net Asset Quality Index for Zhejiang Jingxin Pharmaceutical Co Ltd from 2001 to 2025, covering 25 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002020 stock market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 72.3% | CN¥5.87 Billion | CN¥8.12 Billion | CN¥2.25 Billion | ▲ +1.5 pp |
| 2024 | 70.8% | CN¥6.00 Billion | CN¥8.48 Billion | CN¥2.48 Billion | ▲ +1.4 pp |
| 2023 | 69.4% | CN¥5.54 Billion | CN¥7.99 Billion | CN¥2.45 Billion | ▼ -0.9 pp |
| 2022 | 70.2% | CN¥5.17 Billion | CN¥7.36 Billion | CN¥2.19 Billion | ▼ -5.2 pp |
| 2021 | 75.4% | CN¥4.84 Billion | CN¥6.42 Billion | CN¥1.58 Billion | ▲ +6.0 pp |
| 2020 | 69.4% | CN¥3.93 Billion | CN¥5.67 Billion | CN¥1.73 Billion | ▲ +3.4 pp |
| 2019 | 66.0% | CN¥3.71 Billion | CN¥5.63 Billion | CN¥1.91 Billion | ▼ -5.6 pp |
| 2018 | 71.6% | CN¥3.57 Billion | CN¥4.99 Billion | CN¥1.42 Billion | ▼ -9.3 pp |
| 2017 | 80.9% | CN¥3.97 Billion | CN¥4.90 Billion | CN¥938.43 Million | ▲ +7.1 pp |
| 2016 | 73.7% | CN¥2.43 Billion | CN¥3.29 Billion | CN¥864.23 Million | ▼ -3.2 pp |
| 2015 | 76.9% | CN¥2.26 Billion | CN¥2.94 Billion | CN¥679.39 Million | ▲ +9.2 pp |
| 2014 | 67.7% | CN¥1.40 Billion | CN¥2.06 Billion | CN¥666.12 Million | ▲ +6.0 pp |
| 2013 | 61.8% | CN¥817.98 Million | CN¥1.32 Billion | CN¥506.65 Million | ▲ +2.4 pp |
| 2012 | 59.4% | CN¥772.58 Million | CN¥1.30 Billion | CN¥528.40 Million | ▼ -4.9 pp |
| 2011 | 64.2% | CN¥766.17 Million | CN¥1.19 Billion | CN¥426.39 Million | ▲ +30.5 pp |
| 2010 | 33.7% | CN¥320.13 Million | CN¥949.15 Million | CN¥629.02 Million | ▲ +0.2 pp |
| 2009 | 33.5% | CN¥307.17 Million | CN¥917.22 Million | CN¥610.06 Million | ▲ +1.7 pp |
| 2008 | 31.8% | CN¥303.19 Million | CN¥953.08 Million | CN¥649.89 Million | ▲ +2.3 pp |
| 2007 | 29.5% | CN¥299.61 Million | CN¥1.02 Billion | CN¥716.18 Million | ▼ -8.6 pp |
| 2006 | 38.1% | CN¥294.62 Million | CN¥772.85 Million | CN¥478.23 Million | ▼ -12.8 pp |
| 2005 | 50.9% | CN¥289.64 Million | CN¥568.91 Million | CN¥279.27 Million | ▼ -10.2 pp |
| 2004 | 61.1% | CN¥284.03 Million | CN¥465.14 Million | CN¥181.11 Million | ▲ +26.9 pp |
| 2003 | 34.2% | CN¥88.44 Million | CN¥258.80 Million | CN¥170.36 Million | ▼ -0.4 pp |
| 2002 | 34.6% | CN¥63.02 Million | CN¥182.37 Million | CN¥119.35 Million | ▲ +7.9 pp |
| 2001 | 26.7% | CN¥40.67 Million | CN¥152.50 Million | CN¥111.83 Million | — |